Le‐Qun Li

4.5k total citations · 1 hit paper
104 papers, 2.7k citations indexed

About

Le‐Qun Li is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Le‐Qun Li has authored 104 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Hepatology, 50 papers in Surgery and 44 papers in Epidemiology. Recurrent topics in Le‐Qun Li's work include Hepatocellular Carcinoma Treatment and Prognosis (90 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (43 papers) and Liver Disease Diagnosis and Treatment (32 papers). Le‐Qun Li is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (90 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (43 papers) and Liver Disease Diagnosis and Treatment (32 papers). Le‐Qun Li collaborates with scholars based in China, Hong Kong and Japan. Le‐Qun Li's co-authors include Jian‐Hong Zhong, Bang‐De Xiang, Liang Ma, Wen‐Feng Gong, Ke Yang, Gui‐Sheng Xie, Tao Peng, Yanyan Wang, Xinping Ye and Xue‐Mei You and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Le‐Qun Li

98 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

2018 349 citations Anthony W.H. Chan, Jian‐Hong Zhong et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Le‐Qun Li China	28	2.2k	1.1k	853	524	480	104	2.7k
Ryoko Kuromatsu Japan	27	2.0k 0.9×	888 0.8×	633 0.7×	485 0.9×	606 1.3×	88	2.6k
Cheng‐Yuan Hsia Taiwan	31	2.5k 1.2×	1.7k 1.5×	1.1k 1.3×	633 1.2×	562 1.2×	122	3.3k
Bang‐De Xiang China	30	2.1k 1.0×	1.3k 1.1×	743 0.9×	842 1.6×	842 1.8×	163	3.4k
Chiaki Kagebayashi Japan	7	1.9k 0.9×	1.4k 1.2×	430 0.5×	363 0.7×	455 0.9×	8	2.3k
Alex S. Befeler United States	20	2.1k 1.0×	1.6k 1.4×	898 1.1×	347 0.7×	451 0.9×	48	2.9k
Jiamei Yang China	21	1.7k 0.8×	801 0.7×	577 0.7×	616 1.2×	538 1.1×	51	2.6k
Masahiro Takita Japan	26	1.4k 0.6×	745 0.6×	301 0.4×	411 0.8×	397 0.8×	77	2.1k
Lætitia Fartoux France	24	1.6k 0.8×	1.6k 1.4×	427 0.5×	429 0.8×	546 1.1×	67	3.1k
Kuang‐Liang King Taiwan	24	1.2k 0.6×	661 0.6×	788 0.9×	342 0.7×	544 1.1×	58	2.1k
Lvnan Yan China	20	1.2k 0.6×	813 0.7×	557 0.7×	436 0.8×	453 0.9×	84	1.9k

Countries citing papers authored by Le‐Qun Li

Since Specialization

Citations

This map shows the geographic impact of Le‐Qun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le‐Qun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le‐Qun Li more than expected).

Fields of papers citing papers by Le‐Qun Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Le‐Qun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le‐Qun Li. The network helps show where Le‐Qun Li may publish in the future.

Co-authorship network of co-authors of Le‐Qun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Le‐Qun Li. A scholar is included among the top collaborators of Le‐Qun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Le‐Qun Li. Le‐Qun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xingzhi, Zhihong Tang, Xiaobo Wang, et al.. (2024). The Role of Timing of Progression and Early Salvage Surgery in Unresectable Hepatocellular Carcinoma Treated with TACE Plus TKIs and PD‑1 Inhibitors. Journal of Hepatocellular Carcinoma. Volume 11. 1641–1652. 1 indexed citations

Liu, Lei, Kang Chen, Rong‐Rui Huo, et al.. (2022). Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC. Frontiers in Oncology. 11. 783339–783339. 10 indexed citations

Li, Minjun, Rong‐Rui Huo, Xiumei Liang, et al.. (2021). Clinical effect of re-hepatic resection versus radiofrequency ablation in treatment of recurrent hepatocellular carcinoma in Asia: A Meta-analysis. 37(5). 1103–1109. 1 indexed citations

Zhong, Jian‐Hong, et al.. (2019). Paraneoplastic Syndrome May be a Favorable Prognostic Factor in Patients with Hepatocellular Carcinoma Following Hepatectomy. 2(1). 2 indexed citations

Ma, Liang, et al.. (2019). Comparison of the effect on the prognosis of HCC in terms of different surgical approaches for hepatic inflow occlusion. Translational Cancer Research. 8(4). 1506–1516.

Zhong, Jian‐Hong, Kang Chen, Bhavesh K. Ahir, et al.. (2018). Transarterial embolization for hepatocellular adenomas: Case report and literature review. SHILAP Revista de lepidopterología.

Chan, Anthony W.H., Jian‐Hong Zhong, Sarah Berhane, et al.. (2018). Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. Journal of Hepatology. 69(6). 1284–1293. 349 indexed citations breakdown →

Li, Zihui, Jiazhou Ye, Jie Chen, et al.. (2018). The impact of anatomical resection for hepatocellular carcinoma with microvascular invasion on early tumor recurrence. Zhonghua gan-dan waike zazhi. 24(1). 18–22. 1 indexed citations

Zhong, Jian‐Hong, Jie Zhang, Bin Chen, et al.. (2018). Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion. The American Journal of Surgery. 217(4). 739–744. 56 indexed citations

10.

Liao, Ying‐Yang, Xue‐Mei You, Alessandro Cucchetti, et al.. (2017). Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy. PLoS ONE. 12(3). e0174222–e0174222. 10 indexed citations

11.

Jiang, Jinghang, Jiye Zhu, Peipei Yang, et al.. (2017). Comparison of hepatectomy with or without hepatic inflow occlusion in patients with hepatocellular carcinoma: a single-center experience. Minerva Medica. 108(4). 324–333. 7 indexed citations

12.

Yuan, Shengxian, Jie Wang, Yuan Yang, et al.. (2016). The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature. Clinical Cancer Research. 23(1). 289–297. 27 indexed citations

13.

Ye, Jiazhou, Zhibo Xie, Tao Bai, et al.. (2016). Postoperative adjuvant transarterial chemoembolization after curative resection reduces early recurrence of hepatocellular carcinoma. Zhonghua gan-dan waike zazhi. 22(4). 217–222. 1 indexed citations

14.

Chen, Zu-Shun, Shao‐Liang Zhu, Lu‐Nan Qi, & Le‐Qun Li. (2016). Long-term survival and prognosis for primary clear cell carcinoma of the liver after hepatectomy. OncoTargets and Therapy. Volume 9. 4129–4135. 10 indexed citations

15.

Zhong, Jian‐Hong, et al.. (2015). Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis. BMJ Open. 5(10). e008263–e008263. 9 indexed citations

16.

Pan, Linghui, Lin Wang, Ke Yang, et al.. (2015). Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival. Asian Pacific Journal of Cancer Prevention. 16(13). 5541–5547. 21 indexed citations

17.

Zhong, Jian‐Hong, et al.. (2014). Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review. Tumor Biology. 35(10). 9459–9468. 21 indexed citations

18.

Zhong, Jian‐Hong, et al.. (2013). Methylenetetrahydrofolate Reductase Gene Polymorphism and Risk of Type 2 Diabetes Mellitus. PLoS ONE. 8(9). e74521–e74521. 26 indexed citations

19.

Ye, Jiazhou, Feixiang Wu, Zhao Yin-nong, Le‐Qun Li, & Xue‐Mei You. (2012). Recurrence after anatomic versus nonanatomic resection for hepatocellular carcinoma: a Meta-analysis. Zhonghua gan-dan waike zazhi. 18(8). 582–588.

20.

Li, Le‐Qun. (2011). Postoperative transarterial chemoembolization on patients with hepatocellular carcinoma:a systematic review. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact